Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

The skin's layers protect, sense, and regulate the body's internal balance, but can be prone to cancer.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

The term "porokeratotic adnexal ostial nevus" is proposed to unify overlapping skin conditions involving eccrine and hair follicles.

Enlarged sweat gland ducts may indicate scarring hair loss.

Most cutaneous adnexal tumors examined were benign and resembled common skin tumors.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

A woman died from cancer that spread from a long-standing cyst on her abdomen.

Eccrine sweat gland's clear cells likely cause excessive sweating in hyperhidrosis.

Porokeratotic eccrine and hair follicle nevus is a very rare skin disorder possibly caused by a GJB2 gene mutation.

A 15-year-old with KID syndrome developed a rare skin condition called PEHFN.

Widened sweat ducts are a very specific sign of scarring hair loss.